SecBot SecBot

CRL

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
NYSE· Services-Commercial Physical & Biological Research· CIK 0001100682 Biotech & Drug Discovery
$335.52 −2.45 (−0.72%)
Nov 16 4:00 PM ET · prev $337.97
Market cap
$16.3B
Large cap
Consensus
Buy
77% Buy or better · 22 analysts
Median target
$375.00
+12% · range $145.00–400.00
1 year
+106.2%
from $162.74 · Nov 17
30 days
+11.8%
from $300.02
52-week range
$149.93–376.10
−11% from high · low May 18
Avg volume 20D
1.31M
shares / day
Short interest
2.99M
≈6.2% of shares · +5.4%
Days to cover
2.2
at average volume
Insider net
−$52.1M
1 buyer · 6 sellers · since May 31
New fund stakes
8
Q3 2026 13F · 1 exit
Filing reports
17
analyzed by SecBot
SecBot read BULLISH 11 reports · 90 days
Balance 0 bearish · 3 bullish · 8 neutral oldest → newest, height = score
Avg score ·High conf. 9/11

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider bought $3.0K at an average $297.43. 6 insiders sold $52.1M. Price is 13% above their cost.

  • InstitutionsMIXED

    Q3 2026: 52 added (8 new), 40 trimmed or exited. Largest new: Artisan Partners Limited Partnership $42.1M, Natixis $12.4M.

  • AnalystsBULLISH

    17 of 22 rate it Buy or better. Median target $375.00 (+12%).

  • Short sellersSTEADY

    Short interest +5.4% to 2.99M shares. 2.2 days to cover, ≈6.2% of shares.

  • TrendUPTREND

    8% above its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 4.

Who's buying

13F· Q3 2026
8
new positions
1
exit
$54.4M
in new stakes · top 2 shown
FundMoveSharesValue
FMR LLCADD5,971,701$1.8B
Invesco Ltd.TRIM1,852,539$546.5M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ADD1,000,635$299.1M
DIMENSIONAL FUND ADVISORS LPTRIM933,588$275.4M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPDOUBLED876,972$258.7M
Allspring Global Investments Holdings, LLCTRIM887,518$254.6M
Neuberger Berman Group LLCTRIM626,427$184.8M
JPMORGAN CHASE & COADD437,644$130.3M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

22 analysts
Buy 77% rate it Buy or better
Strong Buy7Buy10Hold5Sell0Strong Sell0
12-month targets · 14 analysts

Price is inside the target range. Median implies +12%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 5, 2026UBS
MAINTAIN
MAINTAINBuy
Nov 5, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Nov 5, 2026Barclays
MAINTAIN
MAINTAINOverweight
Nov 5, 2026Evercore ISI Group
MAINTAIN
MAINTAINOutperform
Oct 13, 2026Morgan Stanley
MAINTAIN
MAINTAINOverweight
Sep 28, 2026Jefferies
MAINTAIN
MAINTAINBuy
Congressional trades
CRL trades disclosed by members of Congress, with disclosure delay.
1 members · 1 buys / 0 sells
DateMemberType AmountDisclosed
May 15, 2026 Ro KhannaDHouse Spouse account · Charles River Laboratories International Inc BUY $1K–$15K Jun 9, 2026 +25d

Washington

Corporate Lobbying

4 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$3.0K
bought · 1 insider
$52.1M
sold · 6 insiders
+12.8%
vs their $297.43 cost
DateInsiderTypeValue
Nov 6, 2026
Knell Michael Gunnar
SVP, Finance and CAO
Nov 6, 2026
TAX W/H$203.1K
Oct 22, 2026
FOSTER JAMES C
Director
Oct 22, 2026
SELL$8.4M
Oct 22, 2026
FOSTER JAMES C
Director
Oct 22, 2026
EXERCISE$5.9M
Oct 21, 2026
Parisotto Shannon M
CEVP, Disc & Safety Assessment
Oct 21, 2026
EXERCISE$526.9K
Oct 21, 2026
Parisotto Shannon M
CEVP, Disc & Safety Assessment
Oct 21, 2026
SELL$742.5K
Oct 5, 2026
Parisotto Shannon M
CEVP, Disc & Safety Assessment
Oct 5, 2026
SELL$302.6K
Oct 5, 2026
Parisotto Shannon M
CEVP, Disc & Safety Assessment
Oct 5, 2026
EXERCISE$204.5K
Sep 30, 2026
Coleman Glenn
EVP & Chief Financial Officer
Sep 30, 2026
BUY$3.0K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Short side

FINRA· Oct 30, 2026
2,987,094
shares short
+5.4%
vs prior settlement
2.2
days to cover
≈6.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 10, 2026 SEC
Invesco Ltd. filed an amended Schedule 13G for Charles River Laboratories, reporting beneficial ownership of 1,852,539…
SC 13G/A · Impact 2/10
Nov 9, 2026 SEC
Charles River Laboratories announced it has entered definitive agreements to acquire Frontage Holdings Corporation's…
8-K · Impact 5/10
Nov 6, 2026 Insider
Knell Michael Gunnar surrendered for taxes 649 shares
SVP, Finance and CAO @ $313.02 ($203.1K)
Nov 4, 2026 Earnings result
CRL Q3 2026 Earnings: EPS $3.09 (+2.9% vs est)
Oct 22, 2026 Insider
FOSTER JAMES C sold 24,042 shares
Director @ $350.00 ($8.4M)
Oct 22, 2026 Insider
FOSTER JAMES C acquired via exercise 24,042 shares
Director @ $244.41 ($5.9M)
Sep 30, 2026 Inst.
FMR LLC · ADD
5,971,701 shares ($1.8B)
Reddit
Recent posts
All social signals and their track records

SecBot reports

17 filings · 4 bullish · 1 bearish · 1 mixed · 11 neutral
All CRL filing & press-release reports (17)